PROCEPT BioRobotics Corp. (PRCT)
17.16
+0.14
(+0.82%)
USD |
NASDAQ |
Oct 02, 16:00
17.17
+0.01
(+0.06%)
After-Hours: 20:00
PROCEPT BioRobotics Enterprise Value : 831.94M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 831.94M |
| October 01, 2026 | 823.93M |
| September 30, 2026 | 892.63M |
| September 29, 2026 | 892.63M |
| September 28, 2026 | 837.10M |
| September 25, 2026 | 834.23M |
| September 24, 2026 | 851.41M |
| September 23, 2026 | 885.18M |
| September 22, 2026 | 904.65M |
| September 21, 2026 | 909.23M |
| September 18, 2026 | 954.45M |
| September 17, 2026 | 964.19M |
| September 16, 2026 | 962.47M |
| September 15, 2026 | 954.45M |
| September 14, 2026 | 1.053B |
| September 11, 2026 | 1.016B |
| September 10, 2026 | 998.53M |
| September 09, 2026 | 1.037B |
| September 08, 2026 | 1.072B |
| September 04, 2026 | 1.153B |
| September 03, 2026 | 1.073B |
| September 02, 2026 | 1.107B |
| September 01, 2026 | 1.047B |
| August 31, 2026 | 1.063B |
| August 28, 2026 | 1.042B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.029B |
| August 26, 2026 | 1.056B |
| August 25, 2026 | 1.086B |
| August 24, 2026 | 1.066B |
| August 21, 2026 | 1.091B |
| August 20, 2026 | 1.036B |
| August 19, 2026 | 1.104B |
| August 18, 2026 | 1.070B |
| August 17, 2026 | 1.057B |
| August 14, 2026 | 1.089B |
| August 13, 2026 | 1.106B |
| August 12, 2026 | 1.066B |
| August 11, 2026 | 1.160B |
| August 10, 2026 | 1.092B |
| August 07, 2026 | 1.018B |
| August 06, 2026 | 996.24M |
| August 05, 2026 | 956.74M |
| August 04, 2026 | 896.06M |
| August 03, 2026 | 901.79M |
| July 31, 2026 | 915.53M |
| July 30, 2026 | 880.03M |
| July 29, 2026 | 873.16M |
| July 28, 2026 | 884.61M |
| July 27, 2026 | 862.29M |
| July 24, 2026 | 805.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Insulet Corp. | 9.546B |
| Globus Medical, Inc. | 9.666B |
| Abbott Laboratories | 196.37B |
| Stryker Corp. | 117.62B |
| AngioDynamics, Inc. | 587.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.86M |
| Revenue (Quarterly) | 94.50M |
| Total Expenses (Quarterly) | 121.36M |
| EPS Diluted (Quarterly) | -0.4707 |
| Gross Profit Margin (Quarterly) | 66.01% |
| Profit Margin (Quarterly) | -28.42% |
| Earnings Yield | -11.35% |
| Normalized Earnings Yield | -11.35 |